curevac

CureVac AG, a Tübingen, Germany-based clinical stage biopharmaceutical company pioneering mRNA-based drugs for vaccines and therapeutics, confirmed it is making internal efforts focused on the development of a coronavirus vaccine with the goal to reach and to protect people and patients worldwide.